Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting   publishing date : 2022 - 05 - 02    save search
American Shared Hospital Services Announces Virtual-Only Annual Shareholder Meeting to be Held on Tuesday, June 21, 2022
Published: 2022-05-02 (Crawled : 14:20) - globenewswire.com
AMS | $3.02 0.84% 0.0% 15K twitter stocktwits trandingview |
Health Services
 | | O: -1.33% H: 2.69% C: 0.0%
services hospital meeting
Itaú Unibanco Holding S.A. 1Q22 Virtual meeting
Published: 2022-05-02 (Crawled : 23:00) - prnewswire.com
ITUB | $6.21 -0.64% 0.0% 18M twitter stocktwits trandingview |
Finance
 | | O: 0.42% H: 1.42% C: 0.63%
Precision Drilling Corporation Holding Virtual-Only 2022 Annual and Special Meeting of Shareholders on May 12
Published: 2022-05-02 (Crawled : 23:00) - globenewswire.com
PDS | $67.87 -0.83% 0.19% 89K twitter stocktwits trandingview |
Industrial Services
 | | O: -0.18% H: 7.8% C: 6.78%
corporation
Acadia Pharmaceuticals Announces FDA Advisory Committee Meeting to Review Resubmission of Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer’s Disease Psychosis Scheduled for June 17, 2022
Published: 2022-05-02 (Crawled : 21:00) - biospace.com/
ACAD | News | $16.59 -0.9% -1.03% 1.3M twitter stocktwits trandingview |
Health Technology
 | | O: -1.41% H: 7.65% C: 7.48%
nuplazid treatment fda drug disease application resubmission alzheimer’s review alzheimer's
Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Published: 2022-05-02 (Crawled : 21:00) - biospace.com/
SGMO | News | $0.493 -5.36% -6.07% 1.2M twitter stocktwits trandingview |
Health Technology
 | | O: -0.24% H: 0.0% C: 0.0%
therapeutics therapy
Phio Pharmaceuticals Announces Upcoming Presentation of PH-894 Data at ASGCT 25th Annual Meeting 2022
Published: 2022-05-02 (Crawled : 21:00) - biospace.com/
PHIO | News | $0.671 -4.14% -4.17% 92K twitter stocktwits trandingview |
Health Technology
 | | O: -4.33% H: 5.06% C: 0.93%
ph-894 presentation ph94
New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting
Published: 2022-05-02 (Crawled : 21:00) - biospace.com/
NBTX | $5.9 3.33% 1.04% 960 twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
asco
Sana Biotechnology to Present Data from Multiple Preclinical Studies at the American Society of Gene and Cell Therapy 25th Annual Meeting
Published: 2022-05-02 (Crawled : 21:00) - globenewswire.com
SANA | $8.58 6.06% 5.71% 1.2M twitter stocktwits trandingview |
| | O: -0.26% H: 3.46% C: 1.79%
preclinical therapy pre-clinical
Codexis to Present Data Highlighting Three Gene Therapy Programs at the ASGCT 25th Annual Meeting
Published: 2022-05-02 (Crawled : 21:00) - globenewswire.com
CDXS | $2.8 -3.45% -2.84% 210K twitter stocktwits trandingview |
Process Industries
 | | O: -0.24% H: 2.92% C: 0.0%
therapy
uniQure Announces Multiple Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Published: 2022-05-02 (Crawled : 21:00) - globenewswire.com
QURE | $4.56 -4.0% -3.94% 640K twitter stocktwits trandingview |
Health Technology
 | | O: -0.76% H: 2.94% C: 1.73%
therapy
Chesapeake Utilities Corporation Announces Capacity Expansion to Meet Growing Customer Demand along Coastal Delaware and Maryland
Published: 2022-05-02 (Crawled : 20:00) - prnewswire.com
CPK | News | $106.89 1.16% 0.0% 150K twitter stocktwits trandingview |
Utilities
 | | O: -0.63% H: 0.0% C: 0.0%
expansion growing capacity corporation
Apellis Announces Detailed 18-Month Results from Phase 3 DERBY and OAKS Studies of Pegcetacoplan for Geographic Atrophy (GA) at ARVO Annual Meeting
Published: 2022-05-02 (Crawled : 20:00) - globenewswire.com
APLS G | $49.93 2.48% 2.25% 1.2M twitter stocktwits trandingview |
Health Technology
 | | O: 2.39% H: 4.58% C: -0.87%
phase 3
Market for Online Dating and Meeting Strangers More than Doubled During Pandemic
Published: 2022-05-02 (Crawled : 18:00) - prnewswire.com
BMBL 4 | $10.44 2.45% 2.58% 2.9M twitter stocktwits trandingview |
| | O: -0.08% H: 7.51% C: 7.26%
MOMO | $5.76 0.7% 0.78% 1.5M twitter stocktwits trandingview |
Technology Services
 | | O: 0.38% H: 4.81% C: -1.12%
MTCH | $31.94 0.79% 0.78% 2.2M twitter stocktwits trandingview |
Technology Services
 | | O: -0.64% H: 2.91% C: 2.6%
BILI | $12.75 10.97% 9.92% 19M twitter stocktwits trandingview |
Technology Services
 | | O: -12.16% H: 8.66% C: 8.57%
dating market
Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Published: 2022-05-02 (Crawled : 16:00) - biospace.com/
SRZN | $8.97 -0.44% -0.45% 9K twitter stocktwits trandingview |
| | O: 1.56% H: 1.53% C: 0.0%
szn-413 treatment research potential diabetic
Enlivex Announces Upcoming Poster Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-05-02 (Crawled : 14:20) - biospace.com/
ENLV | News | $1.5 13.64% 13.16% 120K twitter stocktwits trandingview |
Health Technology
 | | O: 0.53% H: 0.35% C: -6.64%
presentation
Rhythm Pharmaceuticals Presents New Data from Phase 3 Trial Evaluating Setmelanotide in Patients with Bardet-Biedl Syndrome (BBS) at the Pediatric Endocrine Society (PES) 2022 Virtual Annual Meeting
Published: 2022-05-02 (Crawled : 14:20) - biospace.com/
RYTM 4 | $39.71 -0.73% -0.73% 400K twitter stocktwits trandingview |
Health Technology
 | | O: -0.48% H: 0.0% C: 0.0%
endocrine trial setmelanotide phase 3
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
LLY | News | $732.2 -1.81% -0.84% 1.7M twitter stocktwits trandingview |
Health Technology
 | | O: -0.92% H: 0.0% C: 0.0%
VERU | $1.325 3.92% 3.77% 1.5M twitter stocktwits trandingview |
Health Technology
 | | O: 8.28% H: 2.44% C: -19.07%
covid-19 fda sabizabulin granted authorization positive phase 3 emergency use authorization
Equinor Annual General Meeting – Energy Transition Plan
Published: 2022-05-02 (Crawled : 13:20) - globenewswire.com
STOHF | News | $28.0 -3.74% 340 twitter stocktwits trandingview |
Energy Minerals
 | | O: -3.02% H: 0.0% C: 0.0%
EQNR | News | $27.1 -0.07% 3.47% 3M twitter stocktwits trandingview |
Energy Minerals
 | | O: -2.05% H: 1.56% C: 1.38%
energy
Cutera’s AviClear™ Clinical Data Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS)
Published: 2022-05-02 (Crawled : 13:00) - biospace.com/
CUTR | $1.96 -8.84% -9.14% 330K twitter stocktwits trandingview |
Health Technology
 | | O: -12.3% H: 12.17% C: 11.78%
laser
Oncolytics Biotech® and SOLTI Announce Upcoming Poster Presentation at the European Society for Medical Oncology Breast Cancer Meeting
Published: 2022-05-02 (Crawled : 12:20) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 6.06% C: 5.3%
biotech presentation cancer breast cancer
Gainers vs Losers
61% 39%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services
BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services
MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information
RILY | $29.75 36.97% 27.26% 12M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.